Mineral apposition rates provide significant information on long-term effects in BMP-induced bone regeneration

Journal of Biomedical Materials Research - Part A

Volumn 89, Issue 3, 2009, Pages 679-686

  Schopper, Christian ^a   Moser, Doris ^a   Spassova Tzekova, Else ^b   Russmueller, Guenter ^a   Goriwoda, Walter ^a   Lagogiannis, Georgios ^a   Ewers, Rolf ^a   Redl, Heinz ^c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b AlgOss Biotechnologies GmbH   (Austria)

^c FEDERAL RESEARCH AND TRAINING CENTRE FOR FORESTS   (Austria)

Author keywords

Bone regeneration; Calcium phosphate; Fluorescence; Growth factors; Histomorphometry

Indexed keywords

ANIMAL MODEL; AREA FRACTION; BONE FORMATION; BONE REGENERATION; DEFECT SITES; FLUOROCHROME; FRACTIONAL AREA; GROWTH FACTORS; HISTOLOGICAL ANALYSIS; HISTOMORPHOMETRY; IMPLANTATION SITES; LONG-TERM EFFECTS; MINERAL APPOSITION RATE; RHBMP-2;

BIOACTIVITY; BIOLOGICAL MATERIALS; BIOMATERIALS; CALCIUM; CALCIUM ALLOYS; CALCIUM PHOSPHATE; DEFECTS; FLUORESCENCE; MINERALS; MINING; PATIENT MONITORING; PEPTIDES; PHOSPHATES; SILICATE MINERALS;

BONE;

CALCIUM PHOSPHATE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE REGENERATION; BONE REMODELING; CALVARIA; CONTROLLED STUDY; FEMUR; FLUOROCHROME STAINING; HISTOPATHOLOGY; IMPLANT; MORPHOMETRICS; NONHUMAN; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RABBIT;

ANIMALS; BIOCOMPATIBLE MATERIALS; BONE AND BONES; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; HUMANS; MINERALS; RABBITS; TIME FACTORS; WOUND HEALING;

EID: 66249097765     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32012     Document Type: Article

References (25)

1. Phillips FM, Turner AS, Seim HB III, MacLeay J, Toth CA, Pierce AR, Wheeler DL. In vivo BMP-7 (OP-1) enhancement of osteoporotic vertebral bodies in an ovine model. Spine J 2006;6:500-506.
2. Seeherman HJ, Azari K, Bidic S, Rogers L, Li XJ, Hollinger JO, Wozney JM. rhBMP-2 delivered in a calcium phosphate cement accelerates bridging of critical-sized defects in rabbit radii. J Bone Joint Surg Am 2006;88:1553-1565.
3. Jung RE, Schmoekel HG, Zwahlen R, Kokovic V, Hammerle CHF, Weber FE. Platelet-rich plasma and fibrin as delivery systems for recombinant human bone morphogenetic protein- 2. Clin Oral Impl Res 2005;16:676-682.
4. Zheng LW, Wong MCM, Rabie ABM, Cheung LK. Evaluation of recombinant human bone morphogenetic protein-2 in mandibular distraction osteogenesis in rabbits: Effect of dosage and number of doses on formation of bone. Br J Oral Maxillofac Surg 2006;44:487-494.
5. Springer ING, Acil Y, Kuchenbecker S, Bolte H, Warnke PH, Abboud M, Wiltfang J, Terheyden H. Bone graft versus BMP- 7 in a critical size defect-cranioplasty in a growing infant model. Bone 2005;37:563-569.
6. Frost HM. Tetracycline-based histological analysis of bone remodeling. Calcif Tiss Res 1969;3:211-237.
7. Melsen F, Mosekilde L. Tetracycline double-labeling of iliac trabecular bone in 41 normal adults. Calcif Tiss Res 1978;26:99-102.
8. Eriksen EF, Axelrod DW, Melsen F, editors. Bone histomorphometry. New York: Raven Press; 1994.
9. Terheyden H, Warnke P, Dunsche A, Jepsen S, Brenner W, Palmie S, Toth C, Rueger DR. Mandibular reconstruction with prefabricated vascularized bone grafts using recombinant human ostogenic protein-1: An experimental study in miniature pigs. Part II: Transplantation. Int J Oral Maxillofac Surg 2001;30:469-478.
10. Roldan JC, Jepsen S, Miller J, Freitag S, Rueger DC, Acil Y, Terheyden H. Bone formation in the presence of platelet-rich plasma vs. bone morphogenetic protein-7. Bone 2004;34:80-90.
11. Schopper C, Ziya-Ghazvini F, Goriwoda W, Moser D, Wan- schitz F, Spassova E, Lagogiannis G, Auterith A, Ewers R. HA/TCP compounding of a porous CaP biomaterial improves bone formation and scaffold degradation-A long- term histological study. J Biomed Mater Res B Appl Biomater 2005;74:458-167.
12. Donath K, Breuner G. A method for the study of undecalcified bones and teeth with attached soft tissue. The sage-schliff (sawing and grinding) technique. J Oral Pathol 1982;11:198-326.
13. Foldes J, Shih MS, Parfitt AM. Frequency distributions of tet- racyline-based measurements: Implications for the interpretation of bone formation indices in the absence of double-labeled surfaces. J Bone Miner Res 1990;5:1063-1067.
14. Schopper C, Moser D, Spassova E, Goriwoda W, Lagogiannis G, Hoering B, Ewers R, Redl H. Bone regeneration using a naturally grown HA/TCP carrier loaded with rhBMP-2 is independend of barrier membrane effects. J Biomed Mater Res A 2008;85:954-963.
15. Fujita R, Yokohama A, Kawasaki T, Kohgo T. Bone augmentation osteogenesis using hydroxyapatite and β-trical- cium phosphate blocks. J Oral Maxillofac Surg 2003;61: 1045-1053.
16. Frayssinet P, Troulliet JL, Rouquet N, Azimus E, Autefage A. Osseointegration of macroporous calcium phosphate ceramics having a different chemical composition. Biomaterials 1993; 14:423-429.
17. Daculsi G, Passutti N, Martin S, Deudon C, LeGeros RZ, Raher S. Macroporous calcium phosphate ceramic in long bone surgery in human and dogs. Clinical and histological study. J Biomed Mater Res 1990;24:391-396.
18. Nery EB, LeGeros RZ, Lynch KL, Lee K. Tissue response to biphasic calcium phosphate ceramic with different ratios of HA/B-TCP in periodontal osseous defects. J Periodontol 1992;68:729-735.
19. Hashimoto-Uoshima M, Ishikawa I, Kinoshita I, Weng HT, Oda S. Clinical and histological observation of replacement of biphasic calcium phosphate by bone tissue in monkeys. Int J Periodontics Restorative Dent 1995;15:205-213.
20. Allot ME, Delmas PD, Chappard D, Meunier PJ. Trabecular and endocortical bone remodeling in postmenopausal osteoporosis: Comparison with normal postmenopausal women. Osteopor Int 1990;1:41-49.
21. Kimmel DB, Recker RR, Gallagher JC, Vaswani A, Aloia JF. A comparison of iliac histomorphometry in post-menopausal osteoporotic and normal subjects. Bone Miner 1990;11:217- 235.
22. Eriksen EF, Hodgson SF, Eastell R, Cedel SL, O'Fallon WM, Riggs BL. Cancellous bone remodeling in type I (postmenopausal) osteoporosis: Quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels. J Bone Miner Res 1990;5:311-319.
23. Hauge E, Mosekilde LE, Melsen F. Missing observations in bone histomorphometry on osteoporosis: Implications and suggestions for an approach. Bone 1999;25:389-395.
24. Rengachary SS. Bone morphogenetic proteins: Basic concepts. Neurosurg Focus 2002;13:1-6.
25. Seeherman H, Wozney J, Li R. Bone morphogenetic protein delivery systems. Spine 2002;27(Suppl l):16-23.